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Abstract—The acute oral toxicity of the anticoagulant rodenticide diphacinone was found to be over 20 times greater in American
kestrels (Falco sparverius; median lethal dose 96.8mg/kg body weight) compared with Northern bobwhite (Colinus virginianus) and
mallards (Anas platyrhynchos). Modest evidence of internal bleeding was observed at necropsy, although histological examination of
heart, liver, kidney, lung, intestine, and skeletal muscle revealed hemorrhage over a wide range of doses (35.1–675mg/kg). Residue
analysis suggests that the half-life of diphacinone in the liver of kestrels that survived was relatively short, with the majority of the dose
cleared within 7 d of exposure. Several precise and sensitive clotting assays (prothrombin time, Russell’s viper venom time, thrombin
clotting time) were adapted for use in this species, and oral administration of diphacinone at 50mg/kg increased prothrombin time and
Russell’s viper venom time at 48 and 96 h postdose compared with controls. Prolongation of in vitro clotting time reflects impaired
coagulation complex activity, and generally corresponded with the onset of overt signs of toxicity and lethality. In view of the toxicity
and risk evaluation data derived fromAmerican kestrels, the involvement of diphacinone in some raptor mortality events, and the paucity
of threshold effects data following short-term dietary exposure for birds of prey, additional feeding trials with captive raptors are
warranted to characterize more fully the risk of secondary poisoning. Environ. Toxicol. Chem. 2011;30:1213–1222. # 2011 SETAC
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INTRODUCTION
Several anticoagulant rodenticides have been identified as
hazards to predatory and scavenging birds on a worldwide scale.
Various targeted surveillance programs have reported high
detection rates of anticoagulant rodenticide residues in liver
of birds of prey collected in New York (49% of 265 raptors,
1998–2001) [1], France (73% of 30 raptors, 2003) [2], Great
Britain (37% of 351 owls and kestrels, 2003–2005; derived
from Walker et al. [3]), and western Canada (70% of 164 owls,
1988–2003) [4]. Although diagnostic residue concentrations
associated with adverse effects in raptors have yet to be clearly
established, the cause of death was attributed to secondary
rodenticide poisoning in up to 14.6% of the exposure incidents
[1,3,4].
Monitoring avian species during large-scale rodent eradica-
tion operations revealed that several second-generation roden-
ticides can result in nontarget mortality and even population-
level effects through direct ingestion of bait or consumption of
poisoned rodents. For example, baiting operations using bro-
difacoum resulted in> 80% reductions in woodhen (Gallirallus
australis) populations and loss of some raptors (e.g., Austral-
asian harrier, Circus approximans; morepork, Ninox novaesee-
landiae) at Stewart, Ulva, and Inner Chetwode Islands in New
Zealand [5,6]; the death of 13 ravens (Corvus corax) at Langara
Island in British Columbia, Canada [7]; and, most recently, the
apparent poisoning of 320 glaucous-winged gulls (Larus
glaucescens) and 46 bald eagles (Haliaeetus leucocephalus)
on Rat Island, Alaska (http://alaska.fws.gov/ratislandreview-
final.pdf). Such rodent eradication operations use formulations
and application rates that are atypical of more routine use of
second-generation rodenticides. Nonetheless, the global mag-
nitude of nontarget poisoning of wildlife both in pest eradica-
tion programs and in the more routine use of rodenticides is
unknown, and most events probably go unnoticed or are not
reported.
A risk assessment conducted by the U.S. Environmental
Protection Agency (U.S. EPA) in 2002 identified several
rodenticides that pose significant risk to birds and nontarget
mammals, in part because of their toxicity and prolonged
retention in liver [8]. Restrictions on the sale, distribution,
and packaging of brodifacoum, difethialone, bromadiolone,
and difenacoum were subsequently instituted by the U.S.
EPA in 2008 (http://www.epa.gov/pesticides/reregistration/
rodenticides/finalriskdecision.htm). This action will likely be
offset by expanded use of acute toxicants and other antico-
agulant rodenticides, including diphacinone (http://www.regu-
lations.gov/#!documentDetail;D¼EPA-HQ-OPP-2006–0955–
0003). The hazard of diphacinone to nontarget organisms
is inadequately characterized, although significant exposure
and mortality suspected to be related to diphacinone have
been reported for raptors (snowy owl, Nyctea scandiaca; red-
tailed hawk, Buteo jamaicensis; and Cooper’s hawk, Accipiter
Environmental Toxicology and Chemistry, Vol. 30, No. 5, pp. 1213–1222, 2011
# 2011 SETAC
Printed in the USA
DOI: 10.1002/etc.490
All Supplemental Data may be found in the online version of this article.
Portions of this manuscript were presented at the 24th Vertebrate Pest
Conference, February 22–25, 2010, Sacramento, California, USA.
* To whom correspondence may be addressed
(brattner@usgs.gov).
Published online 18 February 2011 in Wiley Online Library
(wileyonlinelibrary.com).
1213
cooperii) [1,9]. Here, we report overt signs of intoxication,
histopathological responses, blood clotting time, residues, and
lethality following diphacinone administration to American
kestrels (Falco sparverius), a well-studied toxicological
model species for raptors [10]. These data, in combination with
similar measurements in Northern bobwhite (Colinus virgin-
ianus), will assist in the development of a pharmacodynamic
model and a more complete risk assessment of diphacinone for
birds.
MATERIALS AND METHODS
Animals
All animal procedures were approved by the Institutional
Animal Care and Use Committee of the Patuxent Wildlife
Research Center. American kestrels, propagated at the captive
colony at Patuxent [11], were reared in vinyl-coated wire
outdoor flight pens (6.1m long 2.4m wide 2.1m high)
containing a nest box, several perches, feed tray and a bowl
of fresh water. Birds were maintained on daily rations of either
Classic Bird of Prey diet (Nebraska Brand) supplemented with
Vionate1 (Gimborn US), dead mice (Mus musculus), or dead
chicken (Gallus gallus) hatchlings. For toxicity tests, kestrels
were moved from flight pens to small outdoor cages (1.2m
long 0.8m wide 0.6m high) with a shade roof, rope
perch, food tray and water bowl, where they were housed
individually.
Acute toxicity of diphacinone
In range-finding trials, serious problems were encountered
because of regurgitation of diphacinone (2-[diphenylacetyl]in-
dan-1,3-dione; CAS 82–66–6; 99.2% purity; Hacco) when
administered as a suspension in vegetable oil or as a neat dose
in a size-0 gelatin capsule (Eli Lilly). Through an iterative
process, a method was developed that minimized regurgitation
through repeated administration of small quantities of dipha-
cinone (1–39mg) as a divided dose over a 24-h period. Briefly,
kestrels (body weight 98–127 g) were transferred from flight
pens to small cages, acclimated for two weeks, fed Classic Bird
of Prey diet, and weighed on the afternoon (1600–1700 h)
before dosing. Individual size-4 gelatin capsules were weighed
on a top-loading balance (1mg sensitivity). Neat diphacinone
was added to the capsule, which was then reweighed to verify
dose. Freeze-dried diet and 5ml FD&C Blue No. 1 food dye
(marker for regurgitation; McCormick) were then added to the
capsule. After an overnight fast with water accessible at all
times, the capsule was administered to the level of the proven-
triculus using a modified pilling device (pet piller; Jorgensen
Laboratories) and a plastic probe that were both 8mm in
diameter. The capsule was chased with 0.2ml distilled water
delivered with a 16-gauge curved ball-point feeding needle
(Popper & Sons). The dosed kestrel was returned to its pen and
immediately presented with a highly desired food item (dead
chicken hatchling). This dosing procedure was repeated up to
three additional times within a 24-h period (i.e., at0900, 1300,
1700, and 0800 h), with the total daily dose ranging from 35.1 to
675mg/kg. In total, 19 kestrels (two-year-old adults randomly
assigned to dose, sexes divided nearly equally among doses)
received diphacinone. Four kestrels that served as controls
were similarly treated, except that capsules did not contain
diphacinone. This acute toxicity study was conducted between
September 14 and October 7, 2009, using a sequential dosing
scheme that attempted to minimize the number of test subjects.
Ambient temperature ranged from 9 to 298C, which is typical
for Maryland, USA, at that time of year. Pens were lined with
Kraft paper to monitor regurgitation, and birds were observed
daily for overt signs of intoxication several times during day-
light for one week. Birds that succumbed during the trial and
survivors (euthanized with carbon dioxide) were necropsied.
Portions of heart, liver, kidney, lung, spleen, intestine, brain,
skeletal muscle, and occasionally other tissues were fixed in
phosphate-buffered formalin for histopathological analysis, and
the liver was frozen at 208C for residue analysis.
Histopathology
In the acute toxicity study, formalin-fixed tissues were
processed (American HistoLabs) using standard procedures
[12]. In general, four 4-mm sections per tissue, in steps of
100mm, were mounted on slides and stained with hematoxylin
and eosin. All sections were consistently examined at a mag-
nification of  200, and, if abnormalities were observed (e.g.,
hemorrhage and other lesions), the tissue was re-examined at a
magnification of  400.
Diphacinone purity and liver residue analysis
Neat diphacinone (5mg) was dissolved in a volumetric flask
with ethyl acetate to a nominal concentration of 1mg/ml and
diluted with a methanol solution containing 5mM tetrabuty-
lammonium dihydrogen phosphate (TBAP) to a nominal con-
centration of 50mg/ml. Samples were analyzed on a C18
column (ODS/H, 4.6 250mm, 5mm column; Keystone Sci-
entific) by reversed phase ion-paired high-performance liquid
(RP-HPLC) chromatography (Agilent 1100 series; Agilent
Technologies). The mobile phase was 5mM TBAP in a pH
7.5 solution of 20:80 water:methanol. Standards and samples
were chromatographed at 1ml/min for 10min and detected at
285 nm. The determined purity for five replicate samples aver-
aged 99.2% with precision (percentage relative standard devia-
tion [SD], coefficient of variation [CV]) of 0.60%.
Kestrel livers were homogenized using liquid nitrogen with a
mortar and pestle, and duplicate samples from each homogenate
were weighed into digestion vessels. Chlorophacinone was
added to each sample to serve as a surrogate standard. Aceto-
nitrile was added to each sample, and samples were extracted at
1258C for 60min using a microwave-accelerated reaction sys-
tem (CEM Corporation). Extracts were then decanted into glass
tubes and reduced to dryness, and residues were reconstituted in
chloroform by vortex mixing and sonication. Hexanes were
added to the samples, which were again vortexed and sonicated.
Sample extracts were then filtered (0.7mm glass fiber syringe
filters; Whatman), cleaned by loading filtrates onto conditioned
(chloroform:hexanes, 2:1) 500mg/3ml Strata-X-AW solid-
phase extraction cartridges (Phenomenex), and eluted with
methanolic solution containing 15mM TBAP. Each eluate
was reduced to dryness, reconstituted in mobile phase (50%
5mM TBAP in pH 8.5 6mM phosphate buffer/50% methanol),
and filtered into vials for RP-HPLC analysis. Diphacinone
concentrations were determined using an Agilent 1100 series
HPLC system and Gemini C18, 3.0 150mm, 3-mm column
(Phenomenex). The aqueous mobile phase was 5mM TBAP
in pH 8.5 6mM potassium phosphate, and the organic mobile
phase was 5mM TBAP in methanol. For each 30-ml injection,
the methanolic component was maintained at 55% for 7min,
followed by a linear gradient to 77.5% over 10min, raised to
85% over the next 10min, and returned to the starting compo-
sition for 7.5min. Diphacinone and surrogate were detected at
325 nm.
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Control quail liver samples spiked with diphacinone at
nominal concentrations of 0.2mg/g and 2mg/g produced sur-
rogate-corrected recoveries SD of 144 14% (n¼ 6) and
109 7% (n¼ 6), respectively. Chlorophacinone was spiked
at a nominal concentration of 3.8mg/g and used as the surrogate
to correct diphacinone recoveries. Surrogate recoveries were
91 4% and 87 2%, respectively, at the two diphacinone
spiking levels. No significant interference was observed at the
retention time for either diphacinone (19.5min) or chloro-
phacinone (23min) in extracted quail livers. The method limit
of detection (three times the signal:noise ratio) and method
limit of quantitation (10 times the signal:noise ratio) were
0.095mg/g and 0.317mg/g, respectively. The precision for
duplicate determinations in liver samples (n¼ 19 dosed
kestrels) averaged 20%.
Effects of diphacinone on clotting time
As part of a study to develop a physiologically based
pharmacokinetic model, kestrels (94–137 g, 1- to 3-year-old
adults) received diphacinone as a single sublethal dose using
procedures employed in the acute toxicity trial. Between Octo-
ber 18 and November 2, 2009 (ambient temperature 2–258C),
treated birds received 50mg/kg body weight, and blood was
drawn at 6, 24, 48, 96, and 168 h after dosing (n¼ 2 males and
2 females per sampling time). Controls (n¼ 2 males and
2 females) received capsules containing only freeze-dried diet
and dye, and blood was collected after 168 h. Blood collection
entailed drawing a 0.9-ml jugular venipuncture sample into a 1-
ml syringe containing 0.1ml of 3.2% sodium citrate (Sigma-
Aldrich). Blood samples were centrifuged (2,000 g for 5min),
and an aliquot of the citrated plasma (250ml) was frozen and
stored at 808C for clotting assays. A combination of assays
(prothrombin time and Russell’s viper venom (RVV) time to
determine vitamin K-dependent coagulopathies, fibrinogen
concentration to rule out nonspecific influences on clotting
time) [13] was used to analyze kestrel samples. Body-weight
change over the course of the trial and liver:body weight ratio at
sacrifice were also determined in this study.
Prothrombin time
In this assay, excess tissue factor and phospholipid (throm-
boplastin) interact with plasma factor VII to form an active
complex, and through a cascade of reactions fibrinogen is
converted to fibrin [13]. Prothrombin time (PT) was determined
using a BBL fibrometer (Becton Dickinson). Instrument per-
formance over one year was assessed using human reference
samples and Simplastin1 (rabbit brain thromboplastin; Trinity
Biotech); PT values were within the reference range provided
by the supplier (mean SD of sample level 1: 16.6 0.5 s,
n¼ 8 assays; sample level 2: 35.5 1.67 s, n¼ 7 assays), and
interassay precision (2.1% and 3.9%, respectively) was satis-
factory.
Because mammalian thromboplastin does not promote rapid
clot formation in avian species, crude chick hatchling throm-
boplastin (CHT) was prepared [13–15]. For the assay of citrated
kestrel plasma samples, a 50-mg aliquot of CHT was suspended
in 2,500ml of 25mM CaCl2 and incubated at 428C for 15min
with intermittent vortexing. The suspension was centrifuged
(1,500 g for 20min), and the supernatant was diluted 1:1 with
25mM CaCl2 (220 mg protein/ml). Kestrel plasma (100ml)
was incubated at 378C for 2min in a sample cup, and the
clotting reaction was initiated by the addition of 200ml diluted
CHT. In preliminary studies, PT of citrated kestrel plasma was
related to CHT dilution (Fig. 1), and PT of kestrel plasma
diluted with 8.3mM Na/K phosphate buffer (pH 7.2) was
relatively stable in reactions containing as little as 50% plasma
(Supplemental Data, Fig. S1). In these preliminary studies,
intraassay precision for duplicate determinations of kestrel
plasma was 2.0 2.2% (n¼ 11), but limited sample volume
permitted only a single determination in diphacinone-treated
kestrels.
Russell’s viper venom time
Russell’s viper venom activates factor X in the common
pathway of the clotting cascade [13]. Reconstituted RVV factor
X activator (American Diagnostica) was diluted 1:10 with
imidazole-buffered saline (IBS; 0.0125M imidazole 0.109M
NaCl, pH 7.4; Sigma-Aldrich) and maintained at room temper-
ature. Kestrel plasma (100ml) was incubated at 378C for 2min,
and 100ml of diluted RVV was added and incubated for 15 s.
The reaction was initiated with 100ml 25mM CaCl2, and RVV
time (RVVT) was determined [16]. In preliminary studies,
RVVT remained relatively stable when kestrel plasma was
diluted by as much as 60% with phosphate buffer (Fig. 2),
and intraassay precision for duplicate determinations was
3.4 4.1% (n¼ 9). Because of limited volume, some plasma
samples from diphacinone-treated kestrels were diluted in
80
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Fig. 1. Clot-promoting potential (prothrombin time) of undiluted and diluted
(1:2 to 1:2,048) chicken hatchling thromboplastin incubated with citrated
American kestrel plasma (Y¼ 67.89 53.54e0.002822(thromboplastin dilution);
R2¼ 0.97).
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Fig. 2. Effect of diluting citrated kestrel plasmawith phosphate buffer (100,
80, 60, 50, 40, 30, and 20% plasma) on Russell’s viper venom clotting time
(Y¼ 30.11þ 94634e0.2845(%plasma); R2¼ 0.99).
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phosphate buffer, and RVVT was adjusted using the dilution
curve.
Thrombin clotting time
This assay determines the time taken for fibrinogen to be
converted to fibrin [16]. The thrombin clotting time assay is an
indicator of fibrinogen concentration in a plasma sample, which
is insensitive to deficiency of vitamin K-dependent clotting
factors. Fibrinogen deficiency resulting from pathophysiologic
conditions or improper sample collection can prolong clotting
time, and in rodenticide toxicity studies it is important to verify
that fibrinogen concentration is adequate to promote clot for-
mation. Assay reagents included bovine thrombin and human
fibrinogen reference material (AMAX Fibrinogen Kit; Trinity
Biotech). A fibrinogen standard curve was prepared (65–
520mg/dl), and kestrel plasma samples were thawed a second
time and diluted 1:10 with IBS. Diluted plasma (200ml total
volume) was incubated at 378C for 2min, and the reaction was
initiated by the addition of 100ml of thrombin reagent. Clotting
time of each sample was transformed to fibrinogen concen-
tration (mg/dl) from the standard curve. In preliminary studies,
intraassay precision for duplicate determinations of kestrel
plasma was 1.8 2.2% (n¼ 9).
Statistical analysis
For the acute toxicity trial, the relation between dose and
survival and the median lethal dose (LD50) of diphacinone in
kestrels was estimated using probit analysis (SAS Institute). A
one-phase exponential decay model (Prism; GraphPad Soft-
ware) was used to describe the relation between clotting time
(PT and RVVT) and dilution of kestrel plasma. To examine
the effects of a sublethal dose of diphacinone, body weight
change, liver:body weight ratio, PT, RVVT, and thrombin
clotting time were tested for homogeneity of variances (Fmax test)
and normality (Shapiro–Wilk test, normal probability plot and
descriptive statistics). The measurement endpoints were tested
by one-way analysis of variance (ANOVA), and clotting times
of diphacinone-treated kestrels (hours postdose) were compared
with the control group using Dunnett’s test.
RESULTS
Acute toxicity of diphacinone
At necropsy, birds were in good body condition with no
evidence of starvation or dehydration. At the highest dosage
levels, birds received three capsules containing diphacinone but
succumbed before receiving the fourth (and final) capsule of
their divided dose, so the actual administered doses were 675,
450, and 300mg/kg (Table 1). These individuals appeared
subdued, died within 8 to 23 h of receiving the initial capsule
of the divided dose, and at necropsy exhibited some macro-
scopic evidence of hemorrhage, but not frank bleeding. There
was no history or evidence of trauma in any of the diphacinone-
treated or control birds. Histological examination of tissues
revealed microscopic hemorrhage in the heart, liver, kidney,
lung, intestine, and skeletal muscle of some individuals (Fig. 3).
At the intermediate doses (266.7 down to 118.6mg/kg), all birds
died within 8 to 47 h, with the exception of a single bird
that exhibited signs of intoxication but then recovered. Gross
necropsy revealed some evidence of hemorrhage in the gastro-
intestinal tract, and the liver was often mottled. Microscopi-
cally, perivascular hemorrhage in the lung and free blood in the
lamia propria of the intestine were consistently found. At
79.0mg/kg, one of three kestrels died after 27 h. At the lowest
doses (52.7 and 35.1mg/kg), all birds survived but exhibited
varying degrees of hemorrhage in liver, lung, lamina propria of
the intestine, and spleen. Kestrels that succumbed often exhib-
ited a progression of toxic signs, including losing balance on
their perch, standing on the floor of the pen rather than on their
perch, being nonreactive when approached, showing subdued
behavior, and showing tan urate deposits. All controls survived
the 7-d trial and did not exhibit gross or microscopic evidence of
hemorrhage other than in the airways (commonly found in birds
euthanized with carbon dioxide). Probit analysis indicated that
survival of kestrels during the 7-d acute toxicity trial was
significantly (p< 0.023) related to the total administered dose
of diphacinone. The LD50 of diphacinone for kestrels was
estimated to be 96.8mg/kg (95% confidence interval 37.9–
219mg/kg), and the slope of the dose–response curve was
6.69 2.94 probit/log10.
Kestrels that died within 8 to 23 h received the largest doses
of diphacinone and had greater concentrations of diphacinone in
liver (32.8–56.3mg/g wet wt) than birds that died 27 to 47 h
postdose (13.4–19.4mg/g wet wt; Table 1 and Fig. 4). Dipha-
cinone appeared to be cleared rapidly from the liver, insofar as
kestrels that survived the 7-d trial generally had concentrations
< 1mg/g.
Sublethal exposure and effects on clotting time
All birds receiving a single oral dose of 50mg diphacinone/
kg (estimated LD10 to LD15) survived to their scheduled time
of sacrifice. No overt signs of toxicity were observed, and body
weight change and liver:body weight ratio were not affected by
diphacinone (p> 0.10). Two of the twenty-four blood samples
were problematic and were excluded. One of these samples had
no detectable fibrinogen, and the other sample was poorly
drawn. Fibrinogen concentration in the remaining 22 samples
was between 41.3 and 160.2mg/dl and did not differ among
sampling times (p> 0.20). Compared with that in the control
group, PT at both 48 and 96 h postdose was significantly
prolonged (2.5-fold and 1.6-fold, respectively; p< 0.05, log-
transformed data), but by 168 h PT had returned to control levels
(Fig. 5). A similar but more pronounced trend was observed for
RVVT, with clotting time prolonged at 48 and 96 h (7.6-fold
and 3.3-fold, respectively; p< 0.05, log-transformed data;
Fig. 6). Notably, one RVVT value at 24 h postdose (173.9 s)
was 4.8-fold greater than mean RVVT of controls (meanSD,
34.2 4.87 s), which is suggestive of coagulopathy.
DISCUSSION
Lethality and overt toxicity
With a relatively small number of individuals in a sequential
acute oral dosing scheme, diphacinone was found to be mod-
erately toxic (LD50 96.8mg/kg) [17] to American kestrels. At
doses that evoked lethality (79mg/kg), birds exhibited ataxia
and subdued behavior but no signs of external bleeding. Based
on the median lethal dose, kestrels were found to be about 20 to
30 times more sensitive to diphacinone than Northern bobwhite
(LD50 2,014mg/kg) [13] and mallards (Anas platyrhynchos;
LD50 3,158mg/kg) [8].
Although diphacinone is linked to secondary poisoning
[1,9], only a few controlled studies have examined its toxicity
in raptors. In an investigation of golden eagles (Aquila chrys-
aetos) fed muscle from diphacinone-treated sheep (Ovis aries;
muscle contained 2.7mg diphacinone/kg) for 5 to 10 d, adverse
effects were observed at much lower concentrations [18] than in
kestrels. One eagle that received a cumulative dose of 1.38mg/
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kg body weight exhibited extreme weakness, and another eagle
that received a cumulative dose of 1.08mg/kg exhibited hem-
orrhage from a wing and ataxia. However, all eagles survived
the trial. In another study, great horned owls (Bubo virginianus)
and a saw-whet owl (Aegolius acadicus) were fed diphacinone-
poisoned mice (Peromyscus maniculatus; 0.01% diphacinone
bait) for 5 d, and barn owls (Tyto alba) were fed diphacinone-
poisoned rats (Rattus norvegicus, R. rattus and R. exulans;
0.005% diphacinone bait) for 10 d [19]. Unfortunately, the
quantity of diphacinone in the poisoned rodents was not analyti-
cally determined. A very rough estimate of the cumulative dose
(ignoring absorption, metabolism, and elimination of diphaci-
none in the rodents) suggests that lethality and severe hemor-
rhage occurred in great horned owls that consumed mice that
had eaten the equivalent of 3 to 4mg diphacinone/kg of owl
weight and a saw-whet owl that had consumed mice that
had eaten the equivalent of about 55mg diphacinone/kg of
owl weight (V.M. Mendenhall, personal communication). No
overt signs of toxicity were observed in barn owls that con-
sumed rats that had eaten the equivalent of about 14 to 17mg
diphacinone/kg of owl weight. In another investigation, com-
munally housed American crows (Corvus brachyrhynchos)
were fed rats poisoned with 0.005% diphacinone for 1 or 6 d
(n¼ 10–11/group) [20]. Based solely on visual observations
while determining time activity budgets, it was suggested that
about 10mg of diphacinone was consumed following a single
day of exposure, whereas 70mg of diphacinone was consumed
by crows in the 6-d-exposure group. One of the crows exposed
for 6 d exhibited blood in the nares and petechial hemorrhages
on the cloacal mucosa. There was evidence of lengthened PT in
both of the dosed groups compared with controls, but white
blood cell counts and clinical plasma chemistries were unaf-
fected.
Fig. 3. Microscopic hematoxylin- and eosin-stained sections of tissues from four different kestrels experimentally dosedwith diphacinone. (A)Liverwith random
foci of hemorrhage (arrows) associatedwithdisruptionofhepatic parenchyma(dose300mg/kg). (B)Skeletalmusclewithhemorrhage (arrows)dissectingbetween
muscle fibers (dose 79.0mg/kg). (C)Lung hemorrhage (arrows) compressing airways (dose 118.6mg/kg). (D) Spleenwith hemorrhage (arrow) evident outside of
its capsule (arrowhead; dose 52.7mg/kg).
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Fig. 4. Scatterplot depicting diphacinone dose and liver residues at time of
death or when kestrels were euthanized.
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Taken together, these studies in raptors (Falconiformes,
Strigiformes) indicate that they are considerably more sensitive
to diphacinone than are bobwhite and mallards, and their
protection may require more substantial safety margins than
afforded by avian game bird species traditionally used in
pesticide registration studies. Although many factors may
account for differences in the sensitivity of raptors to anti-
coagulant rodenticides (e.g., vitamin K 2,3-epoxide reductase
kinetics and inhibition, rodenticide metabolism and clearance),
a recent study demonstrated that hydroxylation rates of warfarin
in the great horned owl and snowy owl (Bubo scandiacus) are
but a small fraction of that observed in mallards, chickens
(Gallus gallus), and laboratory rats [21].
Histopathology, diphacinone residues, and clotting time
Only modest evidence of internal bleeding was apparent at
necropsy in diphacinone-dosed kestrels. This is in contrast to
findings of several anticoagulant rodenticide dosing trials in
raptors that have reported external bleeding and extensive
internal hemorrhages at necropsy [18,19,22,23]. Nonetheless,
Fig. 5. Prothrombin time (individual values andmeanSD) ofAmerican kestrels dosedwith diphacinone (50mg/kg) at 6, 24, 48, 96, and 168 h postdose.n¼No.
of kestrels. Significantly different (p< 0.05) from control collected at 168 h postdose.
Fig. 6. Russell’svipervenomtime (individualvaluesandmeanSD)ofAmericankestrelsdosedwithdiphacinone(50mg/kg)at 6,24, 48, 96, and168 hpostdose.
n¼No. of kestrels. Significantly different (p< 0.05) from control.
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histopathological observations of kestrels document hemor-
rhage in heart, liver, kidney, lung, intestine, and skeletal muscle
over a wide range of doses. Hemorrhage in major organs and
vessels was likely to be a contributor to death, if not the
definitive cause of mortality. However, histopathological obser-
vations alone are generally not considered diagnostic of anti-
coagulant intoxication [24].
Although the half-life of diphacinone in birds has yet to be
reported, data from the present study indicate that it is rapidly
cleared from liver, and presumably other tissues. For example,
kestrels that succumbed to diphacinone (79 to 675mg/kg)
within 48 h of dosing had liver concentrations exceeding
13mg/g wet weight, whereas dosed individuals (35.1–79mg/
kg, and a single bird at 266.7mg/kg) that survived the 7-d trial
had concentrations < 0.8mg/g. A preliminary estimate of the
hepatic diphacinone half-life in kestrels orally dosed with
50mg/kg suggests an overall half-life of 22 h, with an initial
phase (6–48 h postdose) half-life of 7.8 h and terminal phase
(48–168 h postdose) half-life of 59.8 h (K.E. Horak, personal
communication). The hepatic half-life of diphacinone in labo-
ratory rats is about 3 d [25], and in pigs (Sus scrofa) the overall
half-life is about 5.43 d, with an initial phase (1–3 d) half-life of
1.30 d and a terminal phase half-life of 14.12 d [26]. Taken
together, these data suggest that diphacinone is cleared more
rapidly in kestrels than in rats and pigs. Tissue concentrations of
anticoagulant rodenticides associated with adverse effects in
raptors have yet to be definitively established, although hepatic
concentrations of 0.1 to 0.2mg brodifacoum/g wet weight in
combination with evidence of hemorrhage have been consid-
ered diagnostic of death from secondary rodenticide poisoning
[1,4]. Notably, tissue concentrations of anticoagulant rodenti-
cides are likely much greater in acute toxicity studies than in
rodenticide-poisoned wild birds (N.B. Vyas, U.S. Geological
Survey, Patuxent Wildlife Research Center, Beltsville, MD,
personal communication), although histological evidence of
hemorrhage in lung and liver of kestrels was apparent at
0.263 and 0.280mg diphacinone/g wet weight of liver, which
is just above the diphacinone method limit of detection.
Anticoagulant rodenticides irreversibly inhibit vitamin K
epoxide reductase that is necessary for post-translational
carboxylation of the prothrombin group of serine protease
coagulation factors (factors II, VII, IX, and X), and without
the carboxyl group these factors do not assemble on cell surfaces
to form active coagulation complexes [27]. Detection of vitamin
K-dependent coagulopathy in kestrels employed a combination
of assays [13], namely, PT and RVVT, that reflect effects on
clotting factors (for review see Powers [28]) and measurement
of fibrinogen to rule out improper sample collection and other
pathophysiologic conditions (e.g., hepatic synthetic failure,
disseminated intravascular coagulation) that can affect clotting
time [29]. Prolonged clotting time was apparent at 48 h follow-
ing administration of a single oral 50mg diphacinone/kg dose
to kestrels, remained elevated at 96 h postdose, and clearly
exceeded the 25% increase above reference PT values that
is suggestive of anticoagulant exposure [30]. The lag time
between dosing and development of coagulopathy reflects
the half-life clearance of functional coagulation factors (half-
life of factors II, VII, IX, and X in humans are 120, 6, 18, and
65 h, respectively ([31]; see http://www.r2diagnostics.com/
cascade_r2/r2.cascade2007.pdf) and increasing circulation of
des-carboxy dysfunctional factors. Notably, the onset of pro-
longed PT and RVVT corresponds with, and may even precede,
overt toxicity and lethality at the doses used in the acute toxicity
studies. A similar time course of coagulopathy was observed in
a small trial in which kestrels received 50mg/kg as a divided
dose (four capsules administered over a 24-h period) [32]. In the
study of golden eagles fed meat from diphacinone-treated sheep
[18], overt signs of toxicity appeared to correspond to prolonged
PT, and several other studies in various species of birds have
documented prolonged clotting within days of gavage or dietary
exposure to anticoagulant rodenticides [33–36] (K.H. Webster,
2009, Master’s thesis, Simon Fraser University, Burnaby, BC,
Canada).
Risk evaluation
As part of a Special Local Needs pesticide registration
(FIFRA Section 24c) for broadcast application of diphacinone
(0.005% in a grain-based pellet) for the control of rodents and
wild pigs in Hawaii, its hazard to various species of birds was
evaluated by both deterministic [37] and probabilistic [38] risk
assessments. Using the greatest quantity of diphacinone found
in a pig liver (3.07mg/kg) and the available toxicity data for
game birds (LD50> 400mg/kg for bobwhite), Eisemann and
Swift [37] estimated the quantity of pig liver that would have to
be scavenged by a Hawaiian hawk (Buteo solitarius; Federally
listed as endangered) or a Hawaiian short-eared owl (Asio
flammeus sandwichensis; State of Hawaii listed as endangered)
to receive a median lethal dose would be 58.6 kg and 45.6 kg,
respectively. Because diphacinone is now known to be less
toxic to game birds (LD50 2,014mg/kg for bobwhite and LD50
3,158 for mallard) [8,13], the quantity of pig liver that would
have to be scavenged by these Hawaiian raptors would be even
greater than originally estimated [37]. As a preliminary effort to
refine this risk assessment, we used the acute toxicity data for
American kestrels (LD50 96.8mg/kg) from the present study. It
is unlikely that the Hawaiian hawk or short-eared owl would
frequently scavenge pigs, so we employed hepatic diphacinone
residue data from field trials in Hawaii involving black rats
(Rattus rattus; extreme value¼ 12mg/kg) that would more
likely be consumed by the Hawaiian hawk and house mice
(Mus musculus; extreme value¼ 3.8mg/kg) that would more
likely be consumed by the short-eared owl (E.B. Spurr, U.S.
Geological Survey, Pacific Island Ecosystem Research Center,
Honolulu, HI, unpublished data).
Using the aforementioned diphacinone potency estimates for
kestrels and rodent liver residue data in a deterministic approach
[37], a 0.45-kg Hawaiian hawk would have to consume 3.63 kg
of liver from black rats and a 0.35-kg short-eared owl would
have to consume 8.92 kg of liver from house mice in order to
ingest an acute median lethal dose in a 24-h period (Supple-
mental Data, Table S1). If sublethal effects in kestrels were
considered (e.g., 50mg/kg prolonged PT and RVVT, and
35.1mg/kg produced microscopic hemorrhages), the amount
of rodent liver consumed within a 24-h period would be even
lower, 1.32 kg for the hawk and 3.24 kg for the short-eared owl.
These quantities of liver are far greater than the weight of both
the Hawaiian hawk and short-eared owl, so the risk associated
with a single-day exposure to diphacinone would be low.
However, applying the kestrel dose–response curve for lethality
and the rodent liver residue data in the probabilistic-based 1-d
exposure model described by Johnston et al. [38], 50% of male
Hawaiian hawks would have a 1% probability of mortality if
they consumed 0.0035 kg of liver from diphacinone-poisoned
rats (Supplemental Data, Fig. S2). Likewise, 50% of the male
Hawaiian short-eared owls would have a 1% probability of
mortality if they consumed 0.0044 kg of mouse liver (Supple-
mental Data, Fig. S3). Because the dose–response curve does
not permit an estimate of zero probability of lethality, the LD01
1220 Environ. Toxicol. Chem. 30, 2011 B.A. Rattner et al.
was used as a surrogate metric for the no-effect level. For most
wildlife populations, toxicant exposures associated with the
LD01 would likely have little impact on population viability,
although for endangered species this approach may be valid,
insofar as regulations (e.g., Endangered Species Act) do not
permit adverse impacts on such species. If the objective of
natural resource managers is to ensure the viability of a partic-
ular wildlife species, the relative harm of rodenticides should be
compared with the estimated rodent-induced population effects
in the absence of such control.
Given the data for the lowest lethal dose (LLD) for repeated
dietary exposures in mallards (LLD¼ 0.6mg/kg/d) [37] (R.
Long, Wildlife International, Easton, MD, USA, unpublished
data) and the liver residue data from black rats and house mice,
adverse effects could occur if consumption by the hawk
exceeded 0.022 kg of rat liver/d and if consumption by the
short-eared owl exceeded 0.055 kg of mouse liver/d, suggesting
that repeated exposure would constitute a moderate risk to these
species (Supplemental Data, Table S1). Furthermore, prolonged
PT in 5- and 10-d feeding trials in golden eagles [18,37]
occurred following ingestion of 0.11mg diphacinone/kg/d,
suggesting that the lowest observed effect level for the hawk
and short-eared owl could be 0.004 kg of rodent liver/d and
0.010 kg of rodent liver/d, respectively. Under this scenario, the
quantities of liver are < 5% of the body weight of these raptors
(viz. 4 g is 0.9% of hawk body weight and 10 g is 2.9% of owl
body weight), so the Hawaiian hawk and short-eared owl would
be at substantial risk of sublethal exposure. In view of the
paucity of threshold effects data following repeated daily
exposure of raptors to diphacinone, additional feeding trials
in kestrels and owls are warranted to characterize better the
uptake, tissue half-life, PT and RVVT responses, other potential
adverse effects, and overall risk to birds of prey.
CONCLUSIONS
Diphacinone was found to be considerably more toxic to
American kestrels than previously reported in traditionally used
avian wildlife test species. Sublethal effects on blood clotting
were detected at a dose of 50mg/kg, and histological evidence
of hemorrhage was observed at 35.1mg/kg. Measurement of
diphacinone residues in liver suggest that its half-life may be
shorter than that reported for rats and pigs. Recent restrictions
on the use of some second-generation anticoagulant rodenti-
cides (http://www.epa.gov/pesticides/reregistration/rodenti-
cides/finalriskdecision.htm) may result in increased
diphacinone application. In conjunction with its implication
in some mortality events in raptors [1,9], and the paucity of
threshold effects data following repeated daily exposure for
birds of prey, additional feeding trials with diphacinone and
other more toxic anticoagulant rodenticides (e.g., brodifiacoum)
in captive American kestrels and Eastern screech-owls are
warranted to characterize better the risk of secondary poisoning.
SUPPLEMENTAL DATA
Table S1. Acute and sublethal dietary risk to birds from
secondary poisoning by consumption of contaminated rodents.
(36 KB PDF)
Fig. S1. Effect of diluting citrated kestrel plasma with
phosphate buffer (100, 60, 40, 20, and 15% plasma) on pro-
thrombin time (Y¼ 9,605þ 16,289e0.321(%plasma); R2¼ 0.99).
Fig. S2. Probability mortality curve (LD01) of Hawaiian
hawk consuming diphacinone-poisoned black rats.
Fig. S3. Probability mortality curve (LD01) of diphacinone
in Hawaiian short-eared owl consuming poisoned house mice.
(167 KB PDF)
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 Table S1. Acute and sublethal dietary risk to birds from secondary poisoning by consumption of diphacinone contaminated rodentsa
Species Weight      
(kg)
LD50               
(mg/kg)b
LD50 secondary exposure 
(g liver) c
Lowest lethal dose (LLD) 
(mg/kg/day)d 
LLD secondary exposure                
(g liver)c
LOEL sublethal toxicity 
(mg/kg/day)e
Sublethal secondary exposure (g 
liver/day)c
Hawaiian hawk 0.45 96.8 mg/kg 3,630 0.6 22.5 0.11 4.1
Hawaiian short-eared owl 0.35 96.8 mg/kg 8,916 0.6 55.3 0.11 10.1
a Calculated values are the quantities of food required to be ingested to equal the lowest reported avian lethal dose, 50% (LD50), lowest lethal dose (LLD) and lowest-observed-effect level (LOEL).
b Based on median lethal dose for American kestrel (present study).
d Based on lowest lethal dose in mallard acute dietary toxicity study (unpublished data, Long R, Wildlife International, Easton MD, USA).
e Based on lowest observed effect level for prolonged blood clotting time in golden eagles [18].
c Based on greatest diphacinone residue found in black rat liver (12 mg/kg) that could be consumed by an Hawaiian hawk in a 24 h period, and greatest residue found in house mouse liver (3.8 mg/kg) that could be 
consumed by an Hawaiian short-eared owl in a 24 h period (unpublished data, Spurr EB, U.S. Geological Survey, Pacific Island Ecosystem Research Center, Honolulu, HI, USA).
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